Hubei Biocause Pharmaceutical Co (SZSE:000627) Other Long Term Assets : ¥229,822 Mil (As of Mar. 2024)

View and export this data going back to 1996. Start your Free Trial

What is Hubei Biocause Pharmaceutical Co Other Long Term Assets?

Hubei Biocause Pharmaceutical Co's other long-term assets for the quarter that ended in Mar. 2024 was ¥229,822 Mil.

Hubei Biocause Pharmaceutical Co's quarterly other long-term assets declined from Sep. 2023 (¥251,574 Mil) to Dec. 2023 (¥243,504 Mil) but then stayed the same from Dec. 2023 (¥243,504 Mil) to Mar. 2024 (¥229,822 Mil).

Hubei Biocause Pharmaceutical Co's annual other long-term assets increased from Dec. 2021 (¥206,253 Mil) to Dec. 2022 (¥225,285 Mil) and increased from Dec. 2022 (¥225,285 Mil) to Dec. 2023 (¥243,504 Mil).

Hubei Biocause Pharmaceutical Co Other Long Term Assets Historical Data

The historical data trend for Hubei Biocause Pharmaceutical Co's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hubei Biocause Pharmaceutical Co Other Long Term Assets Chart

Hubei Biocause Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long Term Assets

Get a 7-Day Free Trial

172,626.04

180,687.84

206,253.30

225,285.49

243,503.68

Hubei Biocause Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Long Term Assets	Get a 7-Day Free Trial															232,685.27	234,191.54	251,573.59	243,503.68	229,821.94

Hubei Biocause Pharmaceutical Co Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Hubei Biocause Pharmaceutical Co (SZSE:000627) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Insurance » Hubei Biocause Pharmaceutical Co Ltd (SZSE:000627) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

2nd Floor, Building 1, No. 1 Tianshan Road, Guohua Huijin Center, Zhanghe New District, Hubei Province, Jingmen, CHN, 448000

Website

http://www.tianmaogroup.net

Hubei Biocause Pharmaceutical Co Ltd is a China-based company engaged in life insurance, health insurance, accident insurance, and other life insurance businesses, medicine, and chemical businesses. The company generates its revenue in the form of premiums.

Executives

Jiang Hai Hua	Independent director
Fu Yong Jin	Directors, executives
Wu Shi Yan	Supervisors

Hubei Biocause Pharmaceutical Co (SZSE:000627) Headlines

No Headlines